Company Quick10K Filing
Five Below
10-K 2021-01-30 Filed 2021-03-18
10-Q 2020-10-31 Filed 2020-12-03
10-Q 2020-08-01 Filed 2020-09-03
10-Q 2020-05-02 Filed 2020-06-10
10-K 2020-02-01 Filed 2020-03-19
10-Q 2019-11-02 Filed 2019-12-05
10-Q 2019-08-03 Filed 2019-08-29
10-Q 2019-05-04 Filed 2019-06-06
10-K 2019-02-02 Filed 2019-03-28
10-Q 2018-11-03 Filed 2018-12-06
10-Q 2018-08-04 Filed 2018-09-07
10-Q 2018-05-05 Filed 2018-06-07
10-K 2018-02-03 Filed 2018-03-22
10-Q 2017-10-28 Filed 2017-12-01
10-Q 2017-07-29 Filed 2017-08-31
10-Q 2017-04-29 Filed 2017-06-02
10-K 2017-01-28 Filed 2017-03-23
10-Q 2016-10-29 Filed 2016-12-02
10-Q 2016-07-30 Filed 2016-09-01
10-Q 2016-04-30 Filed 2016-06-03
10-K 2016-01-30 Filed 2016-03-24
10-Q 2015-10-31 Filed 2015-12-04
10-Q 2015-08-01 Filed 2015-09-03
10-Q 2015-05-02 Filed 2015-06-04
10-K 2015-01-31 Filed 2015-03-26
10-Q 2014-11-01 Filed 2014-12-05
10-Q 2014-08-02 Filed 2014-09-11
10-Q 2014-05-03 Filed 2014-06-05
10-K 2014-02-01 Filed 2014-03-26
10-Q 2013-08-03 Filed 2013-09-10
10-Q 2013-05-04 Filed 2013-06-13
10-K 2013-02-02 Filed 2013-03-29
10-Q 2012-10-27 Filed 2012-11-30
10-Q 2012-07-28 Filed 2012-09-11
8-K 2021-01-27 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2021-01-12 Regulation FD, Exhibits
8-K 2020-12-02 Earnings, Exhibits
8-K 2020-09-29
8-K 2020-09-02
8-K 2020-06-16
8-K 2020-06-09
8-K 2020-04-24
8-K 2020-03-18
8-K 2020-03-10
8-K 2020-01-13
8-K 2019-12-04
8-K 2019-11-11
8-K 2019-08-28
8-K 2019-06-18
8-K 2019-06-05
8-K 2019-03-27
8-K 2019-01-15
8-K 2018-12-06
8-K 2018-11-27
8-K 2018-10-02
8-K 2018-09-06
8-K 2018-06-19
8-K 2018-06-06
8-K 2018-03-21
8-K 2018-03-05
8-K 2018-01-08

Five Below Financials

FIVE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
37 CAPITAL INC (HHHEF)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
GENOIL INC (GNOLF)
Great Elm Group, Inc. (GEG)
HEALTHY EXTRACTS INC. (HYEX)
Infobird Co., Ltd (IFBD)
1st United Bancorp (FUBC)
Kaixin Auto Holdings (KXINW)
Kensington Capital Acquisition Corp. II (KCAC-UN)
Medigus Ltd. (MDGSW)
2-Track Global (TTG)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTCD)
NLS Pharmaceutics Ltd. (NLSPW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2012-07-282012-10-272013-02-022013-05-042013-08-032013-10-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-282018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Cash187563721650182656352611853266754766575551138413310325222117977
Accounts Receivable
Inventory64846175831158999107167116120124214148156155228154180185272187215228340244268273419
PP&E49549162667011478838414698113120194124132136239149160178308196215246470319337400
Assets1541691901871882162322232442902953033393973933974214775015575626436967357728509521,5921,6591,834
Accounts Payable284028283252343647833942671105858601055178771247395104156104112109188
Long-Term Debt00202020
Liabilities107120119112106127115991111521211211471981491421511991692131952622372572643253379561,0071,188
Stockholders' Equity474971758289117123133139174182192199244254270278331344367381459478508525615636652645
Income Statement ($MM)2012-07-282012-10-272013-02-022013-05-042013-08-032013-10-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-282018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Revenue878717496117111212126152138264154182170326193220199388233283257505296348313603365417377
Cost of Revenue5860102657477128879796157107122117194132147135229159185174297199226211359245271259
Gross Profit2927713043348439564210647605313260736415974998420797122102244120146119
R&D
SG&A2425382734314434403653404846655058558161726910473918796110106
Tax21089791262203432546329510537463093
Net Income1119252253833347442710550817106722251489262910
Cash Flow ($MM)2012-07-282012-10-272013-02-022013-05-042013-08-032013-10-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-282018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Cash Operating-354-126-1248-417-1665-127-2889-1027-1910934-3-141503311-4321-45
Cash Investing-6-5-8-7-7-4-10-10-5-8-11-19-15-55-17126-87-4511-7-98-563612-44-62-26
Cash Financing-101-1530-1811011-0002010215-620-8-30